The National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) (Amendment) Regulations 2014

Amendment of the National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004

2.—(1) The National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004(1) are amended as follows.

(2) In Schedule 2 (drugs on medicines to be ordered only in certain circumstances)—

(a) in the heading to the Schedule, for “on” substitute “or”;

(b) in column 1 of the table (drugs), for the treatment of erectile dysfunction, omit—

(i) “(Caverject), (MUSE), (Viridal)”,

(ii) “(Uprima)”,

(iii) “(Erecnos)” (in both places where it appears),

(iv) “(Viagra)”,

(v) “(Cialis)”, and

(vi) “(Levitra)”;

(c) in column 2 of the table (patient)—

(i) at the beginning of the entry relating to drugs for the treatment of erectile dysfunction, insert “(1) The following patients with erectile dysfunction—”, and

(ii) at the end of paragraph (g) of that entry, insert—

“;

(2) Any patient”; and

(d) in column 3 (condition), opposite “(2) Any patient” in column 2, insert the words “Treatment of a condition other than erectile dysfunction, in respect of which the drug ordered is in receipt of a UK or EU marketing authorisation for the treatment of that condition”.

(1)

S.I. 2004/1022 (W.119); these Regulations have been amended by S.I. 2005/366 (W.32), S.I. 2009/1977 (W.176), S.I. 2009/1838 (W.166), S.I. 2011/1043, S.I. 2012/1916, and S.I. 2013/683 (W.81).